VERACYTE, INC. Goodwill, Foreign Currency Translation Gain (Loss)
VERACYTE, INC. (VCYT) reported Goodwill, Foreign Currency Translation Gain (Loss) of -$13.16 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Income Statement › Other Income
us-gaap:GoodwillForeignCurrencyTranslationGainLoss · last filed 2025-02-28
- VERACYTE, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2024-12-31 was -$16.32M.
- VERACYTE, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2024-09-30 was $10.01M.
- VERACYTE, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2024-06-30 was -$1.75M.
- VERACYTE, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2024-03-31 was -$5.11M.
- VERACYTE, INC. goodwill, foreign currency translation gain (loss) for fiscal 2024 was -$13.16M.
- VERACYTE, INC. goodwill, foreign currency translation gain (loss) for fiscal 2022 was $13.10M.
- VERACYTE, INC. goodwill, foreign currency translation gain (loss) for fiscal 2021 was -$11.90M.
| Period end | Goodwill, Foreign Currency Translation Gain (Loss) 3 month | Goodwill, Foreign Currency Translation Gain (Loss) 6 month | Goodwill, Foreign Currency Translation Gain (Loss) 9 month | Goodwill, Foreign Currency Translation Gain (Loss) 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$16.32M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$6.31M derived: sum of 2 quarters · filed 2025-02-28 | -$8.05M derived: sum of 3 quarters · filed 2025-02-28 | -$13.16M 10-K · filed 2025-02-28 |
| 2024-09-30 | $10.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $8.26M derived: sum of 2 quarters · filed 2024-11-07 | $3.16M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | -$1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$6.85M 10-Q · filed 2024-08-07 | ||
| 2024-03-31 | -$5.11M 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | $13.10M 10-K · filed 2023-03-01 | |||
| 2021-12-31 | -$5.58M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$11.90M 10-K · filed 2022-02-28 | ||
| 2021-09-30 | -$6.32M 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |